DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Razupenem
Razupenem
Novel Β-Lactamase Inhibitors: a Therapeutic Hope Against the Scourge of Multidrug Resistance
Dissertation Submitted in Partial Fulfillment of the Regulations
NIH Public Access Author Manuscript Expert Opin Investig Drugs
Performance Standards for Antimicrobial Susceptibility Testing
Stembook 2018.Pdf
New Quinone Antibiotics Against Methicillin-Resistant S. Aureus
Development of Antibiotics for Gram-Negatives: Where Now?
Table 4A-1. Disk Diffusion QC Ranges for Nonfastidious Organisms
Difficult to Treat Bacterial Infections: Have We Reached a “Dead End”?
Antibacterial Activity and Mode of Action of Lactoquinomycin a from Streptomyces Bacillaris
Disk Diffusion Susceptibility Test Procedure
New Perspectives on Antibacterial Drug Research
State of Antibiotic Development – Staying One Step Ahead?
Evaluation of Next Generation Βlactam Inhibitors Against Penicillinase Producing Methicillin-Resistant Staphylococcus Aureus
M100-S24: Performance Standards for Antimicrobial Susceptibility Testing
New Treatment Options Against Gram-Negative Organisms Matteo Bassetti*, Francesca Ginocchio, Malgorzata Mikulska
(12) United States Patent (10) Patent No.: US 9,694,025 B2 Hirst Et Al
1 Informe Final Del Eps Carnet: 2009-10829 Ref. Eps. Qb
Top View
Characterization and Colistin Susceptibility Of
AMR: Antimicrobial Resistance Data Analysis
Elizabeth T. Escaño-Gallardo, MD, FPPS, FPIDSP 23Rd Annual Convention Pediatric Infectious Disease Society of the Philippines February 19, 2016 Objectives
Literature Search Strategy for Treatment of Stable
K. Pneumoniae
Universidade Do Estado Do Amazonas Mestrado Em
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
( 12 ) United States Patent
Tepzz 5 58¥Zb T
ESCMID Online Lecture Library © by Author
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antibiotic Pipeline Surveillance – 2010 to Mid 2011 Cardinal Health Clinical Affairs (Phase I and Some Early Phase II Not Included)
The Penicillin Binding Proteins
The Enlarging Threat of Antibiotic Resistance
X. Nu/ CI2O I/44 (2006.01) RI A6 IK3I/496 (2006.01) A6 IK3I/542 (2006.01) Patent Application Publication Feb
New Carbapenemase Inhibitors: Clearing the Way for the -Lactams
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri